ÂÜÀòÂÒÂ×

Jonggil Choi serves as VP of Bioinvestment Center, SK Inc. He leads value-up strategies in next-generation bio initiatives of the 2nd largest conglomerate in South Korea, he oversees inorganic opportunities including M&A and investments of SK Group. Mr. Choi has 20+ years of experience in the Pharma Biz. He started his carrier as a researcher at Group’s subsidiary, SK Biopharm, and extended his carrier as a corporate strategy developer. He holds a M.S. in Biochemical Engineering and a B.S. in Life Science from the Korea Advanced Institute of Science and Technology.